WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC

NCT05351320 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: WX-0593 Tablets
DRUG: chemotherapy
RADIATION: Thoracic Radiation Therapy（TRT）

Sponsor

Jinming Yu